Key facts
- This page summarizes Pamela Esposito's Form 4 filing for Replimune Group, Inc. (REPL).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 13 Sep 2023, 21:02.
Pamela Esposito - 11 Sep 2023 Form 4 Insider Report for Replimune Group, Inc. (REPL)
- Reporting relationship
- Chief Business Officer
- Issuer ticker
- REPL
- Reported as of
- 11 Sep 2023
- Net transaction value
- -$94,542
- SEC form
- 4
- Accepted by SEC
- 13 Sep 2023, 21:02:56 UTC
- Prior SEC filing
- 24 Aug 2023
- Next SEC filing
- 20 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shawn Glidden, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Pamela Esposito filed Form 4 for Replimune Group, Inc. (REPL) on 13 Sep 2023.
Change
- Previous filing in this sequence was filed on 24 Aug 2023.
- Current net transaction value: -$94,542.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
REPL
transaction
Common Stock
Options Exercise
- Transaction value
- $17,681
- Shares
- +5,358
- Change %
- +2%
- Price
- $3.30*
- Shares after
- 268,794
- Date
- 11 Sep 2023
- Ownership
- Direct
REPL
transaction
Common Stock
Sale
- Transaction value
- $107,214
- Shares
- -5,358
- Change %
- -2%
- Price
- $20.01
- Shares after
- 263,436
- Date
- 11 Sep 2023
- Ownership
- Direct
- Footnotes
- F1, F2
REPL
transaction
Common Stock
Options Exercise
- Transaction value
- $990
- Shares
- +300
- Change %
- +0.11%
- Price
- $3.30*
- Shares after
- 263,736
- Date
- 12 Sep 2023
- Ownership
- Direct
REPL
transaction
Common Stock
Sale
- Transaction value
- $6,000
- Shares
- -300
- Change %
- -0.11%
- Price
- $20.00
- Shares after
- 263,436
- Date
- 12 Sep 2023
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
REPL
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -5,358
- Change %
- -5.8%
- Price
- $0.000000
- Shares after
- 86,333
- Date
- 11 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,358
- Exercise price
- $3.30
- Footnotes
- F4
REPL
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -300
- Change %
- -0.35%
- Price
- $0.000000
- Shares after
- 86,033
- Date
- 12 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 300
- Exercise price
- $3.30
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 4 footnotes
Footnote F1
The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
Footnote F2
The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.05. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Footnote F3
Following the sales reported on this Form 4, the reporting person continues to beneficially own 263,436 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 491,569 shares of the Issuer's common stock, 376,774 of which are exercisable as of the date hereof.
Footnote F4
The reporting person was granted an option to purchase 134,281 shares of the Issuer's common stock on July 26, 2017. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.